The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Open accessAbstract
Background Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials have been published that have the potential to change clinical care and support the need for an update. Methods Using EULAR standardised operating procedures, the EULAR task force undertook a systematic literature review and sought opinion from 20 experts from 16 countries. We modified existing recommendations and created new recommendations. Results Four overarching principles and 17 recommendations were formulated. We recommend biopsies and ANCA testing to assist in establishing a diagnosis of AAV. For remission induction in life-threatening or organ-threatening AAV, we recommend a combination of high-dose glucocorticoids (GCs) in combination with either rituximab or cyclophosphamide. We recommend tapering of the GC dose to a target of 5 mg prednisolone equivalent/day within 4–5 months. Avacopan may be considered as part of a strategy to reduce exposure to GC in granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA). Plasma exchange may be considered in patients with rapidly progressive glomerulonephritis. For remission maintenance of GPA/MPA, we recommend rituximab. In patients with relapsing or refractory eosinophilic GPA, we recommend the use of mepolizumab. Azathioprine and methotrexate are alternatives to biologics for remission maintenance in AAV. Conclusions In the light of recent advancements, these recommendations provide updated guidance on AAV management. As substantial data gaps still exist, informed decision-making between physicians and patients remains of key relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Avacopan for the Treatment of ANCA-Associated Vasculitis
Jayne, D. R. W., Merkel, P. A., Schall, T. J., & Bekker, P. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023386 · Cited by 1,021
Self-citationRetracted2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37715 · Cited by 6,631
Self-citationRituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Stone, J. H., Merkel, P. A., Spiera, R., Seo, P., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Turkiewicz, A., Tchao, N. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909905 · Cited by 2,762
Self-citationSmolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Jones, R. B., Cohen Tervaert, J. W., Hauser, T., Luqmani, R., Morgan, M. D., Peh, C. A., Savage, C. O., Segelmark, M., Tesar, V., van Paassen, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909169 · Cited by 1,748
Self-citationAgca, R., Heslinga, S. C., Rollefstad, S., Heslinga, M., McInnes, I. B., Peters, M. J. L., Kvien, T. K., Dougados, M., Radner, H., Atzeni, F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209775 · Cited by 1,380
Watts, R., Lane, S., Hanslik, T., Hauser, T., Hellmich, B., Koldingsnes, W., Mahr, A., Segelmark, M., Cohen-Tervaert, J. W., & Scott, D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054593 · Cited by 1,359
Self-citationJayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020286 · Cited by 1,348
Self-citationModification and validation of the Birmingham Vasculitis Activity Score (version 3)
Mukhtyar, C., Lee, R., Brown, D., Carruthers, D., Dasgupta, B., Dubey, S., Flossmann, O., Hall, C., Hollywood, J., Jayne, D., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101279 · Cited by 1,224
Self-citation2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Hellmich, B., Agueda, A., Monti, S., Buttgereit, F., de Boysson, H., Brouwer, E., Cassie, R., Cid, M. C., Dasgupta, B., Dejaco, C., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215672 · Cited by 1,200
Self-citationEULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Yates, M., Watts, R. A., Bajema, I. M., Cid, M. C., Crestani, B., Hauser, T., Hellmich, B., Holle, J. U., Laudien, M., Little, M. A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209133 · Cited by 1,194
Self-citationJayne, D. R. W., Gaskin, G., Rasmussen, N., Abramowicz, D., Ferrario, F., Guillevin, L., Mirapeix, E., Savage, C. O. S., Sinico, R. A., Stegeman, C. A., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010090 · Cited by 1,125
Self-citationMepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Wechsler, M. E., Akuthota, P., Jayne, D., Khoury, P., Klion, A., Langford, C. A., Merkel, P. A., Moosig, F., Specks, U., Cid, M. C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1702079 · Cited by 1,094
Self-citationRituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
Guillevin, L., Pagnoux, C., Karras, A., Khouatra, C., Aumaître, O., Cohen, P., Maurier, F., Decaux, O., Ninet, J., Gobert, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404231 · Cited by 1,090
Self-citationGötestam Skorpen, C., Hoeltzenbein, M., Tincani, A., Fischer-Betz, R., Elefant, E., Chambers, C., da Silva, J., Nelson-Piercy, C., Cetin, I., Costedoat-Chalumeau, N., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208840 · Cited by 1,068
Genetically Distinct Subsets within ANCA-Associated Vasculitis
Lyons, P. A., Rayner, T. F., Trivedi, S., Holle, J. U., Watts, R. A., Jayne, D. R. W., Baslund, B., Brenchley, P., Bruchfeld, A., Chaudhry, A. N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108735 · Cited by 1,010
Self-citationASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
Ramiro, S., Nikiphorou, E., Sepriano, A., Ortolan, A., Webers, C., Baraliakos, X., Landewé, R. B. M., Van den Bosch, F. E., Boteva, B., Bremander, A., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223296 · Cited by 992
EULAR recommendations for the management of primary small and medium vessel vasculitis
Mukhtyar, C., Guillevin, L., Cid, M. C., Dasgupta, B., de Groot, K., Gross, W., Hauser, T., Hellmich, B., Jayne, D., Kallenberg, C. G. M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088096 · Cited by 990
Self-citationde Groot, K., Harper, L., Jayne, D. R. W., Flores Suarez, L. F., Gregorini, G., Gross, W. L., Luqmani, R., Pusey, C. D., Rasmussen, N., Sinico, R. A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-10-200905190-00004 · Cited by 957
Self-citationGuillevin, L., Pagnoux, C., Seror, R., Mahr, A., Mouthon, L., & Toumelin, P. L. (2011) · Medicine · doi:10.1097/md.0b013e318205a4c6 · Cited by 951
Self-citationAndreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Fischer-Betz, R., Forger, F., Moraes-Fontes, M. F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209770 · Cited by 945
Long-term patient survival in ANCA-associated vasculitis
Flossmann, O., Berden, A., de Groot, K., Hagen, C., Harper, L., Heijl, C., Höglund, P., Jayne, D., Luqmani, R., Mahr, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137778 · Cited by 939
Self-citationComarmond, C., Pagnoux, C., Khellaf, M., Cordier, J., Hamidou, M., Viallard, J., Maurier, F., Jouneau, S., Bienvenu, B., Puéchal, X., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37721 · Cited by 937
Self-citationHistopathologic Classification of ANCA-Associated Glomerulonephritis
Berden, A. E., Ferrario, F., Hagen, E. C., Jayne, D. R., Jennette, J. C., Joh, K., Neumann, I., Noël, L.-H., Pusey, C. D., Waldherr, R., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050477 · Cited by 917
Self-citationPlasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Walsh, M., Merkel, P. A., Peh, C.-A., Szpirt, W. M., Puéchal, X., Fujimoto, S., Hawley, C. M., Khalidi, N., Floßmann, O., Wald, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1803537 · Cited by 893
Self-citationFurer, V., Rondaan, C., Heijstek, M. W., Agmon-Levin, N., van Assen, S., Bijl, M., Breedveld, F. C., D'Amelio, R., Dougados, M., Kapetanovic, M. C., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215882 · Cited by 829
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.015 · Cited by 815
Self-citationDe Groot, K., Rasmussen, N., Bacon, P. A., Tervaert, J. W. C., Feighery, C., Gregorini, G., Gross, W. L., Luqmani, R., & Jayne, D. R. W. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21142 · Cited by 801
Self-citationStegeman, C. A., Cohen Tervaert, J. W., de Jong, P. E., & Kallenberg, C. G. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350103 · Cited by 777
Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Fessler, B. J., Ding, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213277 · Cited by 728
Self-citationChung, S. A., Langford, C. A., Maz, M., Abril, A., Gorelik, M., Guyatt, G., Archer, A. M., Conn, D. L., Full, K. A., Grayson, P. C., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41773 · Cited by 702
Self-citationAzathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis
Dhawan, R. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79350-2 · Cited by 674
Hellmich, B., Flossmann, O., Gross, W. L., Bacon, P., Willem Cohen-Tervaert, J., Guillevin, L., Jayne, D., Mahr, A., Merkel, P. A., Raspe, H., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062711 · Cited by 633
Self-citationLevy, J. B., Turner, A. N., Rees, A. J., & Pusey, C. D. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-11-200106050-00009 · Cited by 623
Exley, A. R., Bacon, P. A., Luqmani, R. A., Kitas, G. D., Gordon, C., Savage, C. O. S., & Adu, D. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400222 · Cited by 619
Self-citationHiemstra, T. F., Walsh, M., Mahr, A., Savage, C. O., de Groot, K., Harper, L., Hauser, T., Neumann, I., Tesar, V., Wissing, K.-M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1658 · Cited by 596
Self-citationAGREE II: Advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.001 · Cited by 563
Robson, J. C., Grayson, P. C., Ponte, C., Suppiah, R., Craven, A., Judge, A., Khalid, S., Hutchings, A., Watts, R. A., Merkel, P. A., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221795 · Cited by 492
Self-citationHogan, S. L., Falk, R. J., Chin, H., Cai, J., Jennette, C. E., Jennette, J. C., & Nachman, P. H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00005 · Cited by 479
Bossuyt, X., Cohen Tervaert, J.-W., Arimura, Y., Blockmans, D., Flores-Suárez, L. F., Guillevin, L., Hellmich, B., Jayne, D., Jennette, J. C., Kallenberg, C. G. M., et al. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.140 · Cited by 468
Self-citationLittle, M. A., Nightingale, P., Verburgh, C. A., Hauser, T., De Groot, K., Savage, C., Jayne, D., & Harper, L. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.109389 · Cited by 440
Self-citationHarper, L., Morgan, M. D., Walsh, M., Hoglund, P., Westman, K., Flossmann, O., Tesar, V., Vanhille, P., Groot, K. D., Luqmani, R., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200477 · Cited by 432
Self-citationLionaki, S., Blyth, E. R., Hogan, S. L., Hu, Y., Senior, B. A., Jennette, C. E., Nachman, P. H., Jennette, J. C., & Falk, R. J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34562 · Cited by 424
COHENTERVAERT, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92205-v · Cited by 411
Drosos, G. C., Vedder, D., Houben, E., Boekel, L., Atzeni, F., Badreh, S., Boumpas, D. T., Brodin, N., Bruce, I. N., González-Gay, M. Á., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221733 · Cited by 406
Self-citationPagnoux, C., Mahr, A., Cohen, P., & Guillevin, L. (2005) · Medicine · doi:10.1097/01.md.0000158825.87055.0b · Cited by 405
Self-citationDevaney, K. O., Travis, W. D., Hoffman, G., Leavitt, R., Lebovics, R., & Fauci, A. S. (1990) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199006000-00006 · Cited by 365
Suppiah, R., Robson, J. C., Grayson, P. C., Ponte, C., Craven, A., Khalid, S., Judge, A., Hutchings, A., Merkel, P. A., Luqmani, R. A., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221796 · Cited by 364
Self-citationRisk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis
Walsh, M., Flossmann, O., Berden, A., Westman, K., Höglund, P., Stegeman, C., Jayne, D., & European Vasculitis Study Group (2012) · Arthritis & Rheumatism · doi:10.1002/art.33361 · Cited by 363
Self-citationPlasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis
Klemmer, P. J., Chalermskulrat, W., Reif, M. S., Hogan, S. L., Henke, D. C., & Falk, R. J. (2003) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.08.015 · Cited by 360
Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies
Pusey, C. D., Rees, A. J., Evans, D. J., Peters, D. K., & Lockwood, C. M. (1991) · Kidney International · doi:10.1038/ki.1991.272 · Cited by 358
Kalichman, S. C., & Rompa, D. (2000) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200012010-00007 · Cited by 338
Bozzette, S. A., Finkelstein, D. M., Spector, S. A., Frame, P., Powderly, W. G., He, W., Phillips, L., Craven, D., van der Horst, C., & Feinberg, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321101 · Cited by 332
Cohen, P., Pagnoux, C., Mahr, A., Arène, J., Mouthon, L., Le Guern, V., André, M., Gayraud, M., Jayne, D., Blöckmans, D., et al. (2007) · Arthritis Care & Research · doi:10.1002/art.22679 · Cited by 322
Self-citationRoberts, D. M., Jones, R. B., Smith, R. M., Alberici, F., Kumaratne, D. S., Burns, S., & Jayne, D. R. W. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.11.009 · Cited by 301
Self-citationDevelopment and validation of a renal risk score in ANCA-associated glomerulonephritis
Brix, S. R., Noriega, M., Tennstedt, P., Vettorazzi, E., Busch, M., Nitschke, M., Jabs, W. J., Özcan, F., Wendt, R., Hausberg, M., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.07.020 · Cited by 294
Robson, J., Doll, H., Suppiah, R., Flossmann, O., Harper, L., Höglund, P., Jayne, D., Mahr, A., Westman, K., & Luqmani, R. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203927 · Cited by 291
Self-citation2014 update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
van der Heijde, D., Aletaha, D., Carmona, L., Edwards, C. J., Kvien, T. K., Kouloumas, M., Machado, P., Oliver, S., de Wit, M., & Dougados, M. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206350 · Cited by 290
Schneider, M. M. E., Hoepelman, A. I. M., Schattenkerk, J. K. M. E., Nielsen, T. L., van der Graaf, Y., Frissen, J. P. H. J., van der Ende, I. M. E., Kolsters, A. F. P., & Borleffs, J. C. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272603 · Cited by 282
Moosig, F., Bremer, J. P., Hellmich, B., Holle, J. U., Holl-Ulrich, K., Laudien, M., Matthis, C., Metzler, C., Nölle, B., Richardt, G., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201531 · Cited by 279
Self-citationJones, R. B., Furuta, S., Cohen Tervaert, J. W., Hauser, T., Luqmani, R., Morgan, M. D., Peh, C. A., Savage, C. O., Segelmark, M., Tesar, V., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206404 · Cited by 277
Self-citationDuru, N., van der Goes, M. C., Jacobs, J. W. G., Andrews, T., Boers, M., Buttgereit, F., Caeyers, N., Cutolo, M., Halliday, S., Da Silva, J. A. P., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203249 · Cited by 273
Lyons, P. A., Peters, J. E., Alberici, F., Liley, J., Coulson, R. M. R., Astle, W., Baldini, C., Bonatti, F., Cid, M. C., Elding, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12515-9 · Cited by 272
Self-citationHolle, J. U., Gross, W. L., Latza, U., Nölle, B., Ambrosch, P., Heller, M., Fertmann, R., & Reinhold‐Keller, E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.27763 · Cited by 270
Self-citationRituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
Mohammad, A. J., Hot, A., Arndt, F., Moosig, F., Guerry, M.-J., Amudala, N., Smith, R., Sivasothy, P., Guillevin, L., Merkel, P. A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206095 · Cited by 268
Self-citationWalsh, M., Casian, A., Flossmann, O., Westman, K., Höglund, P., Pusey, C., & Jayne, D. R. W. (2013) · Kidney International · doi:10.1038/ki.2013.131 · Cited by 264
Self-citationWalsh, M., Merkel, P. A., Peh, C. A., Szpirt, W., Guillevin, L., Pusey, C. D., deZoysa, J., Ives, N., Clark, W. F., Quillen, K., et al. (2013) · Trials · doi:10.1186/1745-6215-14-73 · Cited by 243
Self-citationMcAdoo, S. P., Tanna, A., Hrušková, Z., Holm, L., Weiner, M., Arulkumaran, N., Kang, A., Satrapová, V., Levy, J., Ohlsson, S., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.03.014 · Cited by 243
Self-citationPark, J. W., Curtis, J. R., Moon, J., Song, Y. W., Kim, S., & Lee, E. B. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211796 · Cited by 242
Mrak, D., Tobudic, S., Koblischke, M., Graninger, M., Radner, H., Sieghart, D., Hofer, P., Perkmann, T., Haslacher, H., Thalhammer, R., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220781 · Cited by 242
Walsh, M., Merkel, P. A., Mahr, A., & Jayne, D. (2010) · Arthritis Care & Research · doi:10.1002/acr.20176 · Cited by 241
Self-citationSamson, M., Puéchal, X., Devilliers, H., Ribi, C., Cohen, P., Stern, M., Pagnoux, C., Mouthon, L., & Guillevin, L. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.03.003 · Cited by 231
Guillevin, L., Lhote, F., Cohen, P., Jarrousse, B., Lortholary, O., Généreau, T., Léon, A., & Bussel, A. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381116 · Cited by 229
Jones, R. B., Hiemstra, T. F., Ballarin, J., Blockmans, D. E., Brogan, P., Bruchfeld, A., Cid, M. C., Dahlsveen, K., de Zoysa, J., Espigol-Frigolé, G., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214245 · Cited by 228
Self-citationMetzler, C., Miehle, N., Manger, K., Iking-Konert, C., de Groot, K., Hellmich, B., Gross, W. L., Reinhold-Keller, E., & for the German Network of Rheumatic Diseases (2007) · Rheumatology · doi:10.1093/rheumatology/kem029 · Cited by 220
Self-citationKarras, A., Pagnoux, C., Haubitz, M., Groot, K. D., Puechal, X., Tervaert, J. W. C., Segelmark, M., Guillevin, L., & Jayne, D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211123 · Cited by 211
Self-citationUrinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide
Knight, A., Askling, J., Granath, F., Sparen, P., & Ekbom, A. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.019125 · Cited by 204
Cancer incidence in a population‐based cohort of patients with Wegener's granulomatosis
Knight, A., Askling, J., & Ekbom, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10444 · Cited by 199
George, M. D., Baker, J. F., Winthrop, K., Hsu, J. Y., Wu, Q., Chen, L., Xie, F., Yun, H., & Curtis, J. R. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1594 · Cited by 198
Damoiseaux, J., Csernok, E., Rasmussen, N., Moosig, F., van Paassen, P., Baslund, B., Vermeersch, P., Blockmans, D., Cohen Tervaert, J.-W., & Bossuyt, X. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209507 · Cited by 197
Self-citationCharles, P., Perrodeau, É., Samson, M., Bonnotte, B., Néel, A., Agard, C., Huart, A., Karras, A., Lifermann, F., Godmer, P., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3827 · Cited by 197
Self-citationWalsh, M., Catapano, F., Szpirt, W., Thorlund, K., Bruchfeld, A., Guillevin, L., Haubitz, M., Merkel, P. A., Peh, C. A., Pusey, C., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.10.049 · Cited by 196
Self-citationvan der Goes, M. C., Jacobs, J. W. G., Boers, M., Andrews, T., Blom-Bakkers, M. A. M., Buttgereit, F., Caeyers, N., Cutolo, M., Da Silva, J. A. P., Guillevin, L., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.124958 · Cited by 194
Lems, W. F., Dreinhöfer, K., Bischoff-Ferrari, H. A., Blauth, M., Czerwinski, E. J., da Silva, J. A. P., Herrera, A., Hoffmeyer, P. J., Kvien, T. K., Maalouf, G., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210289 · Cited by 181
Spiera, R., Jinich, S., & Jannat-Khah, D. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220604 · Cited by 180
Suppiah, R., Judge, A., Batra, R., Flossmann, O., Harper, L., Höglund, P., Javaid, M. K., Jayne, D., Mukhtyar, C., Westman, K., et al. (2011) · Arthritis Care & Research · doi:10.1002/acr.20433 · Cited by 175
Self-citationEl-Sadr, W. M., Murphy, R. L., Yurik, T. M., Luskin-Hawk, R., Cheung, T. W., Balfour, H. H., Eng, R., Hooton, T. M., Kerkering, T. M., Schutz, M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812243392604 · Cited by 175
Bettiol, A., Urban, M. L., Dagna, L., Cottin, V., Franceschini, F., Del Giacco, S., Schiavon, F., Neumann, T., Lopalco, G., Novikov, P., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.41943 · Cited by 175
Self-citationRituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
Smith, R. M., Jones, R. B., Specks, U., Bond, S., Nodale, M., Aljayyousi, R., Andrews, J., Bruchfeld, A., Camilleri, B., Carette, S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216863 · Cited by 174
Self-citationThoracic Manifestation of Churg-Strauss Syndrome
Choi, Y. H., Im, J.-G., Han, B. K., Kim, J.-H., Lee, K. Y., & Myoung, N. H. (2000) · Chest · doi:10.1378/chest.117.1.117 · Cited by 173
Puéchal, X., Pagnoux, C., Baron, G., Quémeneur, T., Néel, A., Agard, C., Lifermann, F., Liozon, E., Ruivard, M., Godmer, P., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40205 · Cited by 169
Self-citation2020 international consensus on ANCA testing beyond systemic vasculitis
Moiseev, S., Cohen Tervaert, J. W., Arimura, Y., Bogdanos, D. P., Csernok, E., Damoiseaux, J., Ferrante, M., Flores-Suárez, L. F., Fritzler, M. J., Invernizzi, P., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102618 · Cited by 160
Self-citationAlberici, F., Smith, R., Jones, R. B., Roberts, D. M., Willcocks, L. C., Chaudhry, A., Smith, K. G. C., & Jayne, D. R. W. (2014) · Rheumatology · doi:10.1093/rheumatology/keu452 · Cited by 159
Self-citationWalsh, M., Collister, D., Zeng, L., Merkel, P. A., Pusey, C. D., Guyatt, G., Au Peh, C., Szpirt, W., Ito-Hara, T., & Jayne, D. R. W. (2022) · BMJ · doi:10.1136/bmj-2021-064604 · Cited by 158
Self-citationFaurschou, M., Westman, K. W. A., Rasmussen, N., de Groot, K., Floßmann, O., Höglund, P., Jayne, D. R. W., & on behalf of the European Vasculitis Study Group (2012) · Arthritis & Rheumatism · doi:10.1002/art.34547 · Cited by 154
Self-citationClinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides
Solans, R., Fraile, G., Rodríguez‐Carballeira, M., Caminal‐Montero, L., Castillo, M. J., Martínez‐Valle, F., Sáez, L., Blanco, J. J. R., Solanich, X., Oristrell, J., et al. (2017) · Medicine · doi:10.1097/md.0000000000006083 · Cited by 154
Steinfeld, J., Bradford, E., Brown, J., Mallett, S. A., Yancey, S. W., Akuthota, P., Cid, M. C., Gleich, G. J., Jayne, D. R. W., Khoury, P., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.041 · Cited by 154
Self-citationEffect of rituximab on malignancy risk in patients with ANCA-associated vasculitis
van Daalen, E. E., Rizzo, R., Kronbichler, A., Wolterbeek, R., Bruijn, J. A., Jayne, D. R. W., Bajema, I. M., & Rahmattulla, C. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209925 · Cited by 147
Self-citationJayne, D. R. W., Blockmans, D., Luqmani, R. A., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40802 · Cited by 136
Self-citationCartin‐Ceba, R., Diaz-Caballero, L. A., Al‐Qadi, M. O., Τryfon, S., Fervenza, F. C., Ytterberg, S. R., & Specks, U. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39562 · Cited by 135
Gonad evaluation in male systemic lupus erythematosus
Soares, P. M. F., Borba, E. F., Bonfa, E., Hallak, J., Corrêa, A. L., & Silva, C. A. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22660 · Cited by 130
Szpirt, W. M., Heaf, J. G., & Petersen, J. H. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq360 · Cited by 130
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis
Guntur, V. P., Manka, L. A., Denson, J. L., Dunn, R. M., Dollin, Y. T., Gill, M. T., Kolakowski, C. A., Strand, M. J., & Wechsler, M. E. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.09.054 · Cited by 129
Mohammad, A. J., Mortensen, K. H., Babar, J. L., Smith, R., Jones, R. B., Nakagomi, D., Sivasothy, P. R., & Jayne, D. R. W. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.161224 · Cited by 122
Self-citationStassen, P. M., Tervaert, J. W. C., & Stegeman, C. A. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.060301 · Cited by 111
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
Cortazar, F. B., Muhsin, S. A., Pendergraft, W. F., Wallace, Z. S., Dunbar, C., Laliberte, K. A., & Niles, J. L. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.11.004 · Cited by 109
Pepper, R. J., McAdoo, S. P., Moran, S. M., Kelly, D., Scott, J., Hamour, S., Burns, A. P., Griffith, M. E., Galliford, J. W., Levy, J. B., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/key288 · Cited by 108
Self-citationEfficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Teixeira, V. S., Mohammad, A. J., Jones, R. B., Smith, R., & Jayne, D. R. W. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000905 · Cited by 102
Self-citationEfficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Manka, L. A., Guntur, V. P., Denson, J. L., Dunn, R. M., Dollin, Y. T., Strand, M. J., & Wechsler, M. E. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.01.035 · Cited by 95
Moiseev, S. V., Bossuyt, X., Arimura, Y., Blockmans, D., Csernok, E., Damoiseaux, J. G. M. C., Emmi, G., Flores-Suárez, L. F., Hellmich, B., Jayne, D. R. W., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-1628so · Cited by 93
Self-citationMaritati, F., Alberici, F., Oliva, E., Urban, M. L., Palmisano, A., Santarsia, F., Andrulli, S., Pavone, L., Pesci, A., Grasselli, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185880 · Cited by 87
Self-citationMetzler, C., Hellmich, B., Gause, A., Gross, W. L., & de Groot, K. (2004) · PubMed · Cited by 85
Self-citationZäuner, I., Bach, D., Braun, N., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29874 · Cited by 83
Park, J. W., Curtis, J. R., Kim, M. J., Lee, H., Song, Y. W., & Lee, E. B. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1996-6 · Cited by 82
Terrier, B., Darbon, R., Durel, C., HACHULLA, E., Karras, A., Maillard, H., Papo, T., Puéchal, X., Pugnet, G., Quéméneur, T., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01621-3 · Cited by 82
Self-citationPuéchal, X., Pagnoux, C., Baron, G., Lifermann, F., Geffray, L., Quéméneur, T., Saraux, J., Wislez, M., Cottin, V., Ruivard, M., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez139 · Cited by 77
Self-citationGuillevin, L., Cevallos, R., Durand-Gasselin, B., Lhote, F., Jarrousse, B., & Callard, P. (1997) · PubMed · Cited by 74
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines
Tieu, J., Smith, R., Basu, N., Brogan, P. A., D’Cruz, D. P., Dhaun, N., Floßmann, O., Harper, L., Jones, R. B., Lanyon, P., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez640 · Cited by 72
Self-citationMansfield, N., Hamour, S., Habib, A.-M., Tarzi, R. M., Levy, J. B., Griffith, M. E., Cairns, T. D. H., Cook, H. T., Pusey, C. D., & Salama, A. D. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr127 · Cited by 68
Sanders, J., de Joode, A. A. E., DeSevaux, R. G., Broekroelofs, J., Voskuyl, A. E., van Paassen, P., Kallenberg, C. G. M., Tervaert, J. W. C., & Stegeman, C. A. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw211 · Cited by 67
Zeng, L., Walsh, M. W., Guyatt, G. H., Siemieniuk, R. A. C., Collister, D., Booth, M., Brown, P., Farrar, L., Farrar, M. W., Firth, T., et al. (2022) · BMJ · doi:10.1136/bmj-2021-064597 · Cited by 65
Self-citationGao, Y., Chen, M., Ye, H., Yu, F., Guo, X.-H., & Zhao, M.-H. (2008) · Rheumatology · doi:10.1093/rheumatology/ken321 · Cited by 64
Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis
Moura, M. C., Fervenza, F. C., Specks, U., & Sethi, S. M. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab250 · Cited by 63
Samson, M., Puéchal, X., Devilliers, H., Ribi, C., Cohen, P., Bienvenu, B., Terrier, B., Pagnoux, C., Mouthon, L., & Guillevin, L. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.002 · Cited by 62
Self-citationWijetilleka, S., Jayne, D. R. W., Mukhtyar, C. B., Ala, A., Bright, P., Chinoy, H., Harper, L., Kazmi, M. A., Kiani‐Alikhan, S., Li, C. K., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/key394 · Cited by 62
Self-citationEvaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis
McClure, M., Wason, J. M. S., Gopaluni, S., Tieu, J., Smith, R., Jayne, D. R. W., & Jones, R. B. (2019) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001030 · Cited by 62
Self-citationPR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
van Dam, L. S., Dirikgil, E., Bredewold, O. W., Ray, A., Bakker, J. A., van Kooten, C., Rabelink, T. J., & Teng, Y. K. O. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa066 · Cited by 62
Self-citationPatient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
Robson, J. C., Dawson, J., Cronholm, P. F., Ashdown, S., Easley, E., Kellom, K. S., Gebhart, D. E., Lanier, G. E., Milman, N., Peck, J., et al. (2017) · Rheumatology International · doi:10.1007/s00296-017-3855-6 · Cited by 58
Self-citationMendel, A., Ennis, D., Go, E., Bakowsky, V., Baldwin, C., Benseler, S. M., Cabral, D. A., Carette, S., Clements‐Baker, M., Clifford, A. H., et al. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.200721 · Cited by 58
Emmi, G., Rossi, G. M., Urban, M. L., Silvestri, E., Prisco, D., Goldoni, M., & Vaglio, A. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211897 · Cited by 57
Self-citationMiloslavsky, E. M., Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., Clair, E. W. S., Tchao, N. K., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39104 · Cited by 56
Self-citationGranulomatosis With Polyangiitis (Wegener’s)
Springer, J. M., Nutter, B., Langford, C. A., Hoffman, G. S., & Villa‐Forte, A. (2014) · Medicine · doi:10.1097/md.0000000000000020 · Cited by 53
Kronbichler, A., Geetha, D., Smith, R., Egan, A. C., Bajema, I. M., Schönermarck, U., Mahr, A., Anders, H., Bruchfeld, A. N., Cid, M. C., et al. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102986 · Cited by 49
Self-citationSolans, R., Rodríguez‐Carballeira, M., Blanco, J. J. R., Fraile, G., Comet, L. S., Martínez-Zapico, A., Frutos, B., Solanich, X., Fonseca-Aizpuru, E. M., Pasquau, F., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.23912 · Cited by 48
Nezam, D., Porcher, R., Grolleau, F., Morel, P., Beauport, D. T., Faguer, S., Karras, A., Solignac, J., Jourde‐Chiche, N., Maurier, F., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021060771 · Cited by 47
Self-citationWatanabe, H., Sada, K., Matsumoto, Y., Harigai, M., Amano, K., Dobashi, H., Fujimoto, S., Usui, J., Yamagata, K., Atsumi, T., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40538 · Cited by 43
Bénard, V., Farhat, C., Zarandi‐Nowroozi, M., Durand, M., Charles, P., Puéchal, X., Guillevin, L., Pagnoux, C., & Makhzoum, J. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11274 · Cited by 39
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Alunno, A., Najm, A., Machado, P., Bertheussen, H., Burmester, G. R., Carubbi, F., Marco, G. D., Giacomelli, R., Hermine, O., Isaacs, J. D., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221366 · Cited by 39
Self-citationde Joode, A. A. E., Sanders, J., Puéchal, X., Guillevin, L., Hiemstra, T. F., Floßmann, O., Rasmussen, N., Westman, K. W. A., Jayne, D. R. W., & Stegeman, C. A. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kex281 · Cited by 35
Self-citationGopaluni, S., Floßmann, O., Little, M. A., O’Hara, P. V., Bekker, P. J., Jayne, D. R. W., & the European Vasculitis Society (2018) · Arthritis & Rheumatology · doi:10.1002/art.40776 · Cited by 31
Self-citationInterventions for renal vasculitis in adults
Walters, G. D., Willis, N. S., Cooper, T. E., & Craig, J. C. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003232.pub4 · Cited by 31
Longitudinale Effekte des strukturierten Patientenschulungsprogramms für Vaskulitispatienten
Herlyn, K., Gross, W. L., & Reinhold‐Keller, E. (2008) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-008-0290-9 · Cited by 28
Kauffmann, M., Bobot, M., Robert, T., Burtey, S., Couvrat-Desvergnes, G., Lavainne, F., Puéchal, X., Terrier, B., Quéméneur, T., Faguer, S., et al. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03190321 · Cited by 28
Self-citationStevens, K., Frangou, E. A., Shin, J. I., Anders, H., Bruchfeld, A. N., Schönermarck, U., Hauser, T., Westman, K. W. A., Juarez, G. M. F., Floege, J., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac052 · Cited by 28
Self-citationÁlamo, B. S., Schirmer, J. H., Hellmich, B., Jayne, D. R. W., Monti, S. M., Tómasson, G., & Luqmani, R. A. (2023) · RMD Open · doi:10.1136/rmdopen-2023-003083 · Cited by 21
Self-citationArnold, J., Vital, E. M. J., Dass, S., Aslam, A., Rawstron, A. C., Savic, S., Emery, P., & Yusof, M. Y. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803175 · Cited by 20
Springer, J. M., Kermani, T. A., Sreih, A. G., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/17231 · Cited by 18
Jinno, S., Akashi, K., Ōnishi, A., Nose, Y., Yamashita, M., & Saegusa, J. (2021) · Rheumatology International · doi:10.1007/s00296-021-04945-w · Cited by 18
Monti, S. M., Delvino, P., Riboli, M., Rebuffi, C., Xoxi, B., Silvestri, A. D., & Montecucco, C. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab267 · Cited by 17
Self-citationGarbe, N., Schäfer, C., Pilz, A., Schmidt, F., Raberger, K., Wienke, A., & Keyßer, G. (2021) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2021.1972534 · Cited by 8
Collaborators, Terrier, B., Darbon, R., Durel, C., HACHULLA, E., Karras, A., Maillard, H., Papo, T., Puéchal, X., Pugnet, G., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01787-4 · Cited by 2
Self-citation
Metadata
- Authors
- Hellmich, B., Sanchez-Alamo, B., Schirmer, J. H., Berti, A., Blockmans, D., Cid, M. C., Holle, J. U., Hollinger, N., Karadag, O., Kronbichler, A., Little, M. A., Luqmani, R. A., Mahr, A., Merkel, P. A., Mohammad, A. J., Monti, S., Mukhtyar, C. B., Musial, J., Price-Kuehne, F., Segelmark, M., Teng, Y. K. O., Terrier, B., Tomasson, G., Vaglio, A., Vassilopoulos, D., Verhoeven, P., & Jayne, D.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2024-01
- Volume
- 83
- Issue
- 1
- Pages
- 30-47
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W4327568817
- Cited by
- 768
- References
- 151
- FWCI
- 121.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.